Dr.Reddy's Laboratories Ltd (REDY.BO)
BRIEF-Dr.Reddy's Labs' audit of formulations Srikakulum plant Unit II completed with zero observations
* Says audit of formulations Srikakulum Plant unit II, Andhra Pradesh by US FDA, completed with zero observations. Source text - (http://bit.ly/2qnkt2M) Further company coverage:
BRIEF-Dr.Reddy's Laboratories says USFDA approved launch of doxorubicin hydrochloride liposome injection in U.S.
* Announces USFDA approval for launch of doxorubicin hydrochloride liposome injection in U.S. Market Source text - (http://bit.ly/2qQ6RC6) Further company coverage:
* Consensus forecast for March quarter consol profit was 4.27 billion rupees
* Says launch of Ezetimibe and Simvastatin tablets in U.S. market Source text for Eikon: Further company coverage:
* Fresenius ceo sturm says we've had a good q1 but will not provide details
* Dr.Reddy's Laboratories - announces the launch ofprogesterone capsules in the U.S. market". Source text: (http://bit.ly/2pLTt0P) Further company coverage:
* Co, Integra Lifesciences enter agreement to market, distribute Duragen plus and suturable duragen dural regeneration in India
* Have entered into a partnership with Dr. Reddy's laboratories ltd for South African market
* Says the audit of API manufacturing plant at Miryalaguda, by the US FDA, has been completed on February 21, 2017
* Clarifies on news item "Dr. Reddy's announces US district court's opinion relating to patent infringement"